Literature DB >> 34238327

Correction to: Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson's disease model.

Chunni Zhu1, Tina Bilousova1,2, Samantha Focht1, Michael Jun1, Chris Jean Elias1, Mikhail Melnik1, Sujyoti Chandra1, Jesus Campagna1, Whitaker Cohn1, Asa Hatami1, Patricia Spilman1, Karen Hoppens Gylys2, Varghese John3.   

Abstract

Entities:  

Year:  2021        PMID: 34238327      PMCID: PMC8265003          DOI: 10.1186/s13041-021-00816-4

Source DB:  PubMed          Journal:  Mol Brain        ISSN: 1756-6606            Impact factor:   4.041


× No keyword cloud information.

Correction to: Mol Brain (2021) 14:70 https://doi.org/10.1186/s13041-021-00776-9

Following publication of the original article [1], it was noted that due to a typesetting mistake, an incorrect version of Additional file 1 (with regards to the reference numbering) was processed. The correct version of Additional file 1 is attached to this Correction and has been corrected in the original article. The publisher apologises to the authors and readers for the inconvenience caused by this error. Additional file 1. Additional file.
  1 in total

1.  Pharmacological inhibition of nSMase2 reduces brain exosome release and α-synuclein pathology in a Parkinson's disease model.

Authors:  Chunni Zhu; Tina Bilousova; Samantha Focht; Michael Jun; Chris Jean Elias; Mikhail Melnik; Sujyoti Chandra; Jesus Campagna; Whitaker Cohn; Asa Hatami; Patricia Spilman; Karen Hoppens Gylys; Varghese John
Journal:  Mol Brain       Date:  2021-04-19       Impact factor: 4.041

  1 in total
  1 in total

1.  Effects of Pramipexole Combined with Nerve Growth Factor on Cognitive Impairment and Urinary AD7c-NTP Expression in Patients with Parkinson's Disease.

Authors:  Zhengxin Wang; Saiyu Cheng
Journal:  Comput Math Methods Med       Date:  2022-04-26       Impact factor: 2.809

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.